Article Versions Notes

Nakano T, Onoue K, Terada C, Terasaki S, Ishihara S, Hashimoto Y, Nakada Y, Nakagawa H, Ueda T, Seno A, et al. Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function. Journal of Personalized Medicine. 2022; 12(5):792. https://doi.org/10.3390/jpm12050792

Nakano, Tomoya, Kenji Onoue, Chiyoko Terada, Satoshi Terasaki, Satomi Ishihara, Yukihiro Hashimoto, Yasuki Nakada, Hitoshi Nakagawa, Tomoya Ueda, Ayako Seno, and et al. 2022. "Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function" Journal of Personalized Medicine 12, no. 5: 792. https://doi.org/10.3390/jpm12050792

Nakano, T., Onoue, K., Terada, C., Terasaki, S., Ishihara, S., Hashimoto, Y., Nakada, Y., Nakagawa, H., Ueda, T., Seno, A., Nishida, T., Watanabe, M., Hoshii, Y., Hatakeyama, K., Sakaguchi, Y., Ohbayashi, C., & Saito, Y. (2022). Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function. Journal of Personalized Medicine, 12(5), 792. https://doi.org/10.3390/jpm12050792